SOPH — Sophia Genetics SA Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapNeutral

Annual balance sheet for Sophia Genetics SA, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	20-F	20-F	20-F	20-F	20-F
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	265	179	123	80.2	70.3
Net Total Accounts Receivable
Net Total Receivables	7.09	7.89	15.2	8.69	16.5
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	283	196	148	99.4	99.1
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	16	21.4	23.1	19.4	18
Net Goodwill
Net Intangible Assets
Long Term Notes Receivable
Other Long Term Assets
Total Assets	320	244	206	155	163
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	28.6	26.8	35.6	26.8	50.5
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	44.8	43.7	54.7	58.8	116
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Total Equity	275	200	151	96.5	47.1
Total Liabilities & Shareholders' Equity	320	244	206	155	163
Total Common Shares Outstanding